Our Team

Carol A. Marzetta, Ph.D., Chief Scientific Officer
Carol Marzetta has over 15 years of experience in small molecule and biologic drug development in both global pharmaceutical and emerging biotechnology companies. Her background is unique in that she has served as a drug discovery scientist, led and managed product teams through clinical development to launch and built and led R&D portfolio management groups. She specializes in designing and implementing drug development strategies, integrating project and line management team processes, and designing portfolio prioritization and resource allocation processes and methodologies. In the Global Health sector, Carol applies her years of private industry experience to work with key public sector organizations such as WHO, UNICEF, USAID, the World Bank, and the Bill & Melinda Gates Foundation to find solutions that bring private industry and public partners together to accelerate the introduction of medicines and vaccines in the developing world.

<< back